Treatment of Parathyroid Carcinoma with Locally Advanced Disease or Distant Metastases

Parathyroid carcinoma may present in a locally advanced state or with distant spread. This protocol addresses the management of patients whose disease has progressed beyond surgical cure, including those with metastases to distant organs.

Clinical Scenario

This protocol applies to patients with locally advanced parathyroid carcinoma or confirmed distant metastases. Sites of distant spread include:

Lung
Bone
Liver

Parathyroid carcinoma is often locally advanced at presentation, and distant metastases can occur in the lung (40%), bone (30%), and liver (10%).

Treatment Approach

For patients with locally advanced or metastatic parathyroid carcinoma, surgical and locoregional interventions play a central role in tumour burden reduction and control of hormonal secretion — alongside specific medical management for persistent severe hypercalcaemia.

Full sequencing, eligibility criteria, and additional options detailed in the structured protocol →

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.esmoop.2024.103664

PC is often locally advanced and distant metastases can occur in the lung (40%), bone (30%) and liver (10%).

The efficacy of systemic treatment in advanced and metastatic disease is limited; thus, whenever possible, debulking surgery and/or locoregional treatments should be discussed to control tumour burden and hormonal secretion [V, A].

Cinacalcet should be continued in case of persistent severe hypercalcaemia.

View source ↗